FDA Approved: RYKINDO EXTENDED-RELEASE MICROSPHERES — Supplemental Application (Shandong Luye Pharmaceutical Co., Ltd.)

View source ↗

Summary

The FDA approved a supplemental application for RYKINDO Extended-Release Microspheres (risperidone) from Shandong Luye Pharmaceutical Co., Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• RYKINDO EXTENDED-RELEASE MICROSPHERES (risperidone)

Snippet

SUPPL AP for RYKINDO EXTENDED-RELEASE MICROSPHERES (RISPERIDONE)